Review Article

Psychotropic Drugs Promoting Weight Gain Health Risks and Treatment Implications

Authors: W. J. KENNETH ROCKWELL MD, EVERETT H. ELLINWOOD JR., MD, DAVID W. TRADER MD

Abstract

ABSTRACTThe use of psychotropic medication is often associated with weight gain. We provide documentation for this effect and review the mechanisms possibly responsible for it in the case of neuroleptic agents, lithium carbonate, monoamine oxidase inhibitors, and amitriptyline. We also enumerate the undesirable medical consequences of obesity. Failure to take medication because it promotes weight gain is a serious impediment to successful treatment. Strategies that may promote drug compliance and prevent or reduce weight gain are discussed.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References